Peritoneal Cancer
📧 Sign up to get email alerts when something new happens for Peritoneal Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2025-07-02Clinical Trial Update: Personalized Timing of Interval Debulking Surgery in Advanced Ovarian Cancer [Phase 2]
Phase 2 study evaluating personalized timing of interval debulking surgery for advanced ovarian cancer. The trial is currently recruiting.
-
CLINICAL_TRIALS research · 2025-06-30Clinical Trial Update: Phase II Clinical Study of Utidelone Capsule (UTD2) in Patients With Advanced Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer [Phase 2]
Phase II clinical study evaluating Utidelone Capsule (UTD2) in advanced epithelial ovarian, fallopian tube, or primary peritoneal cancer; th…
-
CLINICAL_TRIALS research · 2025-06-27Clinical Trial Update: Surgery for Relapsed Ovarian Cancer in Precision [Phase 1, Phase 2]
A precision medicine-guided surgical approach for relapsed ovarian, fallopian tube, and primary peritoneal cancers is being explored in Phas…
-
CLINICAL_TRIALS research · 2025-06-22Clinical Trial Update: ZEN003694 Combined With Talazoparib in Patients With Recurrent Ovarian Cancer [Phase 2]
A Phase 2 clinical trial is evaluating ZEN003694 in combination with Talazoparib for recurrent ovarian cancer and related gynecologic cancer…
-
CLINICAL_TRIALS research · 2025-06-18Clinical Trial Update: ONC201 Plus Weekly Paclitaxel in Patients With Platinum Refractory or Resistant Ovarian Cancer [Phase 2]
Phase 2 clinical trial evaluating ONC-201 in combination with weekly paclitaxel for platinum-refractory or resistant ovarian cancer; current…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2025-06-04Clinical Trial Update: MT027 Cell Injection in Patients With Advanced Primary or Secondary Peritoneal Tumors [NA]
This clinical trial update describes MT027 cell injection being studied in patients with advanced primary or secondary peritoneal tumors. Th…
-
CLINICAL_TRIALS research · 2025-06-03Clinical Trial Update: Intra-tumoral (IT) Injection of vvDD-hIL2-2-RG-1 for Metastatic Gastrointestinal and Peritoneal Tumors [Phase 1]
Phase 1 study evaluating intra-tumoral injections of vvDD-hIL2-2-RG-1 for metastatic gastric, esophageal, liver, colorectal, and peritoneal …
-
CLINICAL_TRIALS research · 2025-05-23Clinical Trial Update: Study of Pembrolizumab Combination With Chemotherapy in Platinum-sensitive Recurrent Low-grade Serous Ovarian Cancer [Phase 2]
An ongoing Phase 2 study evaluating pembrolizumab in combination with chemotherapy for platinum-sensitive recurrent low-grade serous ovarian…
-
CLINICAL_TRIALS research · 2025-05-22Clinical Trial Update: Testing the Addition of an Anti-cancer Drug, Elimusertib (BAY 1895344) ATR Inhibitor, to the Chemotherapy Treatment (Gemcitabine) for Advanced Pancreatic and Ovarian Cancer, and Advanced Solid Tumors [Phase 1]
A Phase 1 trial is evaluating the addition of Elimusertib, an ATR inhibitor, to gemcitabine for advanced pancreatic and ovarian cancers and …
-
CLINICAL_TRIALS research · 2025-05-21Clinical Trial Update: MT027 in Patients With Advanced Peritoneal Malignancies or Abdominal Metastatic Solid Tumors [Phase 1]
MT027 is being studied in a Phase 1 trial for patients with B7-H3-positive advanced malignant solid tumors, including primary peritoneal can…
-
CLINICAL_TRIALS research · 2025-05-18Clinical Trial Update: A Study Comparing Perioperative Stress Reduction vs. Standard of Care in Ovarian Cancer (PRESERVE) [NA]
A clinical trial named PRESERVE is evaluating perioperative stress reduction versus standard of care in patients with ovarian cancer and rel…
-
CLINICAL_TRIALS research · 2025-05-06Clinical Trial Update: Genetic & Pathological Studies of BRCA1/BRCA2: Associated Tumors & Blood Samples
This clinical trial update describes a Stanford-sponsored study investigating BRCA1/BRCA2-associated tumors and the collection of related tu…
-
CLINICAL_TRIALS research · 2025-04-16Clinical Trial Update: Relacorilant in Combination With Nab-Paclitaxel in Advanced, Platinum-Resistant, High-Grade Epithelial Ovarian, Primary Peritoneal, or Fallopian-Tube Cancer [Phase 3]
This update notes a Phase 3 trial evaluating relacorilant in combination with nab-paclitaxel for advanced platinum-resistant ovarian, primar…
-
CLINICAL_TRIALS research · 2025-04-06Clinical Trial Update: Mirvetuximab Soravtansine (IMGN853), in Folate Receptor Alpha (FRα) High Recurrent Ovarian Cancer [Phase 2]
A Phase 2 clinical trial update for Mirvetuximab soravtansine (IMGN853) in FRα-high recurrent ovarian, fallopian tube, or primary peritoneal…
-
CLINICAL_TRIALS research · 2025-02-21Clinical Trial Update: Genetic Testing in African Americans [NA]
Clinical trial update on genetic testing in African American participants related to ovarian cancer, endometrial cancer, and peritoneal canc…
-
CLINICAL_TRIALS research · 2025-02-12Clinical Trial Update: Development of a Cinical and Biological Database in Ovarian, Fallopian Tube and Peritoneal Cancers [NA]
This entry reports on the development of a clinical and biological database for ovarian, fallopian tube, and peritoneal cancers, sponsored b…
-
CLINICAL_TRIALS research · 2025-02-11Clinical Trial Update: Nab-paclitaxel Versus Sb-taxanes As First-Line Treatment in Advanced Ovarian Cancer [Phase 3]
Phase 3 clinical trial comparing nab-paclitaxel with solvent-based taxanes as first-line therapy for advanced ovarian cancer is currently re…
-
CLINICAL_TRIALS research · 2025-02-10Clinical Trial Update: Surgery Combined With Maintenance Targeted Therapy in the Treatment of Advanced Ovarian Cancer [Phase 2]
Phase 2 clinical trial evaluating the combination of surgery with maintenance targeted therapy for advanced ovarian cancer is currently recr…
-
CLINICAL_TRIALS research · 2025-02-10Clinical Trial Update: Study of Upfront Surgery Versus Neoadjuvant Chemotherapy in Patients With Advanced Ovarian Cancer (SUNNY) [Phase 3]
Phase 3 clinical trial SUNNY compares upfront surgery to neoadjuvant chemotherapy in advanced ovarian cancer. The study is currently active …
-
CLINICAL_TRIALS research · 2025-02-05Clinical Trial Update: Microdevice In Ovarian, Fallopian Tube, And Peritoneal Cancer [Phase 1]
Phase 1 clinical trial of a microdevice for ovarian, fallopian tube, and peritoneal cancer is currently recruiting.
-
CLINICAL_TRIALS research · 2025-01-28Clinical Trial Update: Effects of Cold Atmospheric Plasma (CAP) on Peritoneal Tumor Tissue [NA]
A clinical trial is evaluating Cold Atmospheric Plasma (CAP), specifically J-Plasma, for peritoneal tumor tissue. The study is currently rec…
-
CLINICAL_TRIALS research · 2024-12-31Clinical Trial Update: JSKN003 in Platinum-Resistant, Relapsed Epithelial Ovarian Cancer [Phase 3]
Phase 3 trial update for JSKN003 in platinum-resistant, relapsed epithelial ovarian cancer; the study is currently not yet recruiting.
-
CLINICAL_TRIALS research · 2024-12-04Clinical Trial Update: Epithelial Ovarian Cancer- Staging and Response to Chemotherapy Evaluated by PET/CT
Clinical trial update from Turku University Hospital evaluating how PET/CT staging correlates with chemotherapy response in epithelial ovari…
-
CLINICAL_TRIALS research · 2024-11-27Clinical Trial Update: Post Splenectomy Infections After Surgery for Peritoneal Malignancies (OPSI)
Clinical trial update for the OPSI study evaluating post-splenectomy infections following surgery for peritoneal malignancies. The study is …
-
CLINICAL_TRIALS research · 2024-11-19Clinical Trial Update: HOT: HIPEC in Ovarian Cancer as Initial Treatment [Phase 2]
Phase 2 trial evaluating hyperthermic intraperitoneal chemotherapy (HIPEC) as initial treatment for Stage III/IV ovarian cancer is currently…